HDAC5 and persistent truncus arteriosus: We found that treatment with LMK235, an HDAC5 inhibitor, ameliorated cardiac dysfunction and attenuated ventricular remodeling in TAC mice and Ang II-induced hypertrophy in H9C2 cells.